EU regulator backs Johnson & Johnson's COVID-19 vaccine despite finding possible link to rare blood clots

EU regulator backs Johnson & Johnson’s COVID-19 vaccine despite finding possible link to rare blood clots
Pushkala Aripaka, Anthony Deutsch and John Miller
Reuters
Bookmark
Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file ...
This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
SHANNON STAPLETON/Reuters
Europe’s drug regulator has found a possible link between Johnson & Johnson’s COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.

Related Keywords

United States ,Sabine Straus ,Johnson ,Astrazeneca ,European Medicines Agency ,Reuters ,Coronayellow ,Vaccine ,United ,Europe ,Fema ,Shot ,Case ,University Of Nottingham ,ஒன்றுபட்டது மாநிலங்களில் ,ஸெபீந் ஸ்ட்ராஸ் ,ஜான்சன் ,ராய்ட்டர்ஸ் ,தடுப்பூசி ,ஒன்றுபட்டது ,யூரோப் ,ஈமா ,ஷாட் ,வழக்கு ,பல்கலைக்கழகம் ஆஃப் நாட்டிங்ஹாம் ,